RGPD1 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the RGPD1 protein, a member of the RANBP2-like and GRIP domain-containing protein family. RGPD1 is thought to play a role in various cellular processes, including nuclear transport, RNA processing, and the regulation of gene expression. The protein contains domains that suggest it may interact with other proteins involved in these essential cellular activities, particularly in the context of nuclear-cytoplasmic transport. By inhibiting RGPD1, researchers can disrupt its function, thereby providing insights into its role in these complex cellular processes and elucidating the molecular mechanisms it influences.
The development of RGPD1 inhibitors involves a multi-step process that starts with a detailed structural and functional analysis of the RGPD1 protein. Techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the three-dimensional structure of RGPD1, focusing on its functional domains and potential binding sites for inhibitors. Understanding the protein's structure is crucial for designing inhibitors that can specifically target these regions, thereby blocking its activity. Computational tools, including molecular docking and virtual screening, are then used to identify small molecules that can bind with high affinity to the identified sites on RGPD1. Once potential inhibitors are discovered, they are synthesized and subjected to rigorous in vitro testing to assess their binding properties, specificity, and ability to inhibit RGPD1's activity. Through iterative cycles of chemical optimization, these inhibitors are refined to improve their potency and selectivity. The study of RGPD1 inhibitors not only enhances our understanding of this specific protein's function but also contributes to a broader understanding of the regulatory networks governing nuclear transport, RNA processing, and gene expression in cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor, known to affect multiple signaling pathways, possibly influencing RGPD1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that alters cellular growth and proliferation pathways, potentially affecting RGPD1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, impacting cell survival and growth pathways, possibly linked to RGPD1 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor, affecting MAPK/ERK pathway, potentially altering pathways involving RGPD1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, modifying MAPK/ERK signaling, possibly impacting RGPD1-related pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, influencing inflammatory responses and cellular stress pathways affecting RGPD1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, modulating apoptosis and cellular stress responses, potentially linked to RGPD1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor like LY294002, potentially affecting pathways related to RGPD1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, influencing gene expression, possibly impacting RGPD1-related genes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, affecting protein degradation pathways, potentially linked to RGPD1 activity. | ||||||